Physician profile
Aaron G Purdy
NPI 1750567228
$1,075.64
in general payments reported to CMS, 2019-2025
17 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $25.03 · 2021: $42.41 · 2022: $233 · 2023: $299 · 2024: $41.71 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $601.45 | 2022-2025 | |
| Novo Nordisk INC | $108.46 | 2019-2025 | Ozempic, Rybelsus |
| Axsome Therapeutics, INC. | $67.23 | 2025 | Auvelity |
| Lilly USA, LLC | $48.61 | 2019-2023 | Mounjaro |
| Genzyme Corporation | $32.03 | 2025 | |
| Mylan Specialty L.P. | $30.14 | 2019-2022 | |
| Philips North America LLC | $26.70 | 2021-2022 | |
| Lundbeck LLC | $24.66 | 2025 | Vyepti |
| Medicomp INC | $24.62 | 2023 | Telepatch Cardiac Monitor |
| Glaxosmithkline, LLC. | $16.03 | 2023 | Trelegy Ellipta |
| Dexcom, INC. | $15.76 | 2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.36 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.06 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.58 | 2022 | |
| Ironshore Pharmaceuticals INC. | $13.53 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $12.27 | 2019 | |
| Pfizer INC. | $11.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Purdy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.